Universe Pharmaceuticals (Universe Pharmaceuticals) Debt-to-Equity : 0.14 (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Universe Pharmaceuticals Debt-to-Equity?

Universe Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $5.48 Mil. Universe Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil. Universe Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $39.53 Mil. Universe Pharmaceuticals's debt to equity for the quarter that ended in Sep. 2023 was 0.14.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Universe Pharmaceuticals's Debt-to-Equity or its related term are showing as below:

UPC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.07 Med: 0.13 Max: 0.27
Current: 0.14

During the past 6 years, the highest Debt-to-Equity Ratio of Universe Pharmaceuticals was 0.27. The lowest was 0.07. And the median was 0.13.

UPC's Debt-to-Equity is ranked better than
66.51% of 848 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs UPC: 0.14

Universe Pharmaceuticals Debt-to-Equity Historical Data

The historical data trend for Universe Pharmaceuticals's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universe Pharmaceuticals Debt-to-Equity Chart

Universe Pharmaceuticals Annual Data

Trend

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Debt-to-Equity

Get a 7-Day Free Trial

0.20

0.13

0.07

0.09

0.14

Universe Pharmaceuticals Semi-Annual Data
	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial						0.07	0.07	0.09	0.09	0.14

Competitive Comparison of Universe Pharmaceuticals's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Universe Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universe Pharmaceuticals's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Universe Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Universe Pharmaceuticals's Debt-to-Equity falls into.

Universe Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Universe Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.482	+	0)	/	39.533
	=	0.14

Universe Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.482	+	0)	/	39.533
	=	0.14

Universe Pharmaceuticals (NAS:UPC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Universe Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Universe Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Universe Pharmaceuticals (Universe Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Universe Pharmaceuticals Inc (NAS:UPC) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

265 Jingjiu Avenue, Economic & Technological Development Zone, Jinggangshan, Jiangxi, Ji’an, CHN

Website

http://www.universe-pharmacy.com

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.